A research team at Hong Kong Polytechnic University (PolyU) has designed a robotic arm to facilitate self-help and upper...
Qingsongchou, China's largest healthcare platform launched the first full industrial chain blockchain insuranc...
Adagene, an innovative antibody engineering and discovery company based in Suzhou, China as well as San Francisco, Calif...
GeneQuantum Healthcare, a hi-tech enterprise founded in Suzhou Industrial Park in 2013 and Biocytogen, a hi-tech biologi...
Schrödinger, a privately-held company revolutionizing drug discovery through advanced computational methods and ent...
Innovent Biologics a China Suzhou-based biopharmaceutical company, completes its initial public offering in Hong Kong, w...
Professor Gabriel Leung of the University of Hong Kong (HKU) has been elected a member of the US National Academy of Med...
Editage, the flagship business unit of Cactus Communications, has appointed Frank Xu as the Managing Director of China O...
MGI, a subsidiary of BGI Group, introduced its newest model of genetic sequencer, MGISEQ-T7, which vastly improves speed...
XtalPi Inc., a Boston-Shenzhen computation-driven biotech startup integrating quantum physics, artificial intelligence (...
Fullerton Healthcare Corporation Limited, a leading vertically integrated healthcare platform in Asia Pacific, anno...
Agena Bioscience (Agena), a San-Diego-based develops, manufactures, and supplies genetic analysis systems and reage...
Reistone Biopharma Company Limited, a clinical stage biopharmaceutical company headquartered in Shanghai has announced&...
Cancer Genetics, Inc., a leader in enabling precision medicine for immuno-oncology and genomics through molecular marker...
Hutchison China MediTech Limited (Chi-Med) has initiated a Phase I study of HMPL-523, its novel spleen tyrosine kinase (...
Changchun Changsheng Life Sciences Ltd has been charged with a huge fine of $1.3 billion for falsifying production recor...
JHL Biotech announced that the National Medical Products Administration of the PRC (NMPA) has approved JHL's Phase I and...
Curetis, a developer of next-level molecular diagnostic solutions, has announced that it has significantly expanded its ...
